Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Development of semiquantitative ultrasound scoring system to assess cartilage in rheumatoid arthritis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Elevated faecal calprotectin is linked to worse disease status in axial spondyloarthritis: results from the SPARTAKUS cohort

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Secular trends in the incidence and prevalence of gout in Denmark from 1995 to 2015: a nationwide register-based study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Cardiovascular Manifestations of Systemic Sclerosis: A Danish Nationwide Cohort Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Arielle Mendel
  • Sasha Bernatsky
  • Christian A Pineau
  • Yvan St-Pierre
  • John G Hanly
  • Murray B Urowitz
  • Ann E Clarke
  • Juanita Romero-Diaz
  • Caroline Gordon
  • Sang-Cheol Bae
  • Daniel J Wallace
  • Joan T Merrill
  • Jill Buyon
  • David A Isenberg
  • Anisur Rahman
  • Ellen M Ginzler
  • Michelle Petri
  • Mary Anne Dooley
  • Paul Fortin
  • Dafna D Gladman
  • Kristján Steinsson
  • Rosalind Ramsey-Goldman
  • Munther A Khamashta
  • Cynthia Aranow
  • Meggan Mackay
  • Graciela Alarcón
  • Susan Manzi
  • Ola Nived
  • Andreas Jönsen
  • Asad A Zoma
  • Ronald F van Vollenhoven
  • Manuel Ramos-Casals
  • Giuillermo Ruiz-Irastorza
  • Sam Lim
  • Kenneth C Kalunian
  • Murat Inanc
  • Diane L Kamen
  • Christine A Peschken
  • Søren Jacobsen
  • Anca Askanase
  • Jorge Sanchez-Guerrero
  • Ian N Bruce
  • Nathalie Costedoat-Chalumeau
  • Evelyne Vinet
Vis graf over relationer

OBJECTIVES: To assess the prevalence of combined hormonal contraceptives (CHCs) in reproductive-age women with SLE with and without possible contraindications and to determine factors associated with their use in the presence of possible contraindications.

METHODS: This observational cohort study included premenopausal women ages 18-45 years enrolled in the SLICC Registry ⩽15 months after SLE onset, with annual assessments spanning 2000-2017. World Health Organization Category 3 or 4 contraindications to CHCs (e.g. hypertension, aPL) were assessed at each study visit. High disease activity (SLEDAI score >12 or use of >0.5 mg/kg/day of prednisone) was considered a relative contraindication.

RESULTS: A total of 927 SLE women contributed 6315 visits, of which 3811 (60%) occurred in the presence of one or more possible contraindication to CHCs. Women used CHCs during 512 (8%) visits, of which 281 (55%) took place in the setting of one or more possible contraindication. The most frequently observed contraindications were aPL (52%), hypertension (34%) and migraine with aura (22%). Women with one or more contraindication were slightly less likely to be taking CHCs [7% of visits (95% CI 7, 8)] than women with no contraindications [9% (95% CI 8, 10)].

CONCLUSION: CHC use was low compared with general population estimates (>35%) and more than half of CHC users had at least one possible contraindication. Many yet unmeasured factors, including patient preferences, may have contributed to these observations. Further work should also aim to clarify outcomes associated with this exposure.

OriginalsprogEngelsk
TidsskriftRheumatology (Oxford, England)
Vol/bind58
Udgave nummer7
Sider (fra-til)1259-1267
Antal sider9
ISSN1462-0324
DOI
StatusUdgivet - 1 jul. 2019

Bibliografisk note

© The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

ID: 58902316